{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:50:22Z","timestamp":1774543822080,"version":"3.50.1"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:p>Hidradenitis suppurativa (HS), increasingly recognized as a multisystem inflammatory condition, is associated with heightened frailty and may also confer an underappreciated vulnerability to impaired bone health through chronic inflammation and related comorbidities. Emerging evidence, including reduced bone mineral density and degraded microarchitecture in HS, suggests a plausible link to osteopenia, osteoporosis and fracture risk, warranting greater clinical vigilance. To optimize long-term outcomes, integrating bone health and frailty assessments into HS care and pursuing robust longitudinal research will be essential to clarify mechanisms, refine risk stratification and inform targeted prevention strategies.<\/jats:p>","DOI":"10.1093\/ced\/llaf545","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:06:41Z","timestamp":1765544801000},"page":"646-647","source":"Crossref","is-referenced-by-count":0,"title":["Hidradenitis suppurativa and bone health: cracks beneath the surface? Comment on\u00a0\u2018Frailty in hidradenitis suppurativa: a\u00a0case\u2013control study\u2019"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-8738","authenticated-orcid":false,"given":"Aparna","family":"Potluru","sequence":"first","affiliation":[{"name":"Department of Dermatology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-7233","authenticated-orcid":false,"given":"Yasmin","family":"Nikookam","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St George's Hospital, St George's University Hospitals NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2026032611543024400_llaf545-B1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ced\/llaf519","article-title":"Frailty in hidradenitis suppurativa: a case\u2013control study","volume":"51","author":"Howard-James","year":"2026","journal-title":"Clin Exp Dermatol"},{"key":"2026032611543024400_llaf545-B2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bjd\/ljad345","article-title":"Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape","volume":"190","author":"Krueger","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026032611543024400_llaf545-B3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/atm-20-4708","article-title":"Bone mineral density, osteopenia, osteoporosis, and fracture risk in patients with atopic dermatitis: a systematic review and meta-analysis","volume":"9","author":"Wu","year":"2021","journal-title":"Ann Transl Med"},{"key":"2026032611543024400_llaf545-B4","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.3390\/jcm9113712","article-title":"Bone mineral density, osteoporosis, and fracture risk in adult patients with psoriasis or psoriatic arthritis: a systematic review and meta-analysis of observational studies","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Med"},{"key":"2026032611543024400_llaf545-B5","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.2340\/actadv.v102.3504","article-title":"Bone metabolism in patients with hidradenitis suppurativa: a case\u2013control study","volume":"102","author":"Navarro","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"2026032611543024400_llaf545-B6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00296-022-05136-x","article-title":"The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era","volume":"42","author":"Evangelatos","year":"2022","journal-title":"Rheumatol Int"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf545\/65875870\/llaf545.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/646\/65875870\/llaf545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/4\/646\/65875870\/llaf545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:54:39Z","timestamp":1774540479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/4\/646\/8379258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":6,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,13]]},"published-print":{"date-parts":[[2026,3,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf545","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,12,13]]}}}